TRILOGIC PHARMA LLC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and medical technology are ANIMAL ETHICS PTY LTD, GUANGXI XINYE BIOLOGICAL TECH CO LTD and INDUCE BIOLOG INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | China | 1 | |
#6 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Alur Hemant H | 12 |
#2 | Harwick James A H | 9 |
#3 | Johnston Thomas P | 4 |
#4 | Mondal Pravakar | 3 |
#5 | Harwick James Ah | 3 |
#6 | Pravakar Mondal | 1 |
#7 | Harwick James | 1 |
#8 | Alur Hemant | 1 |
#9 | Hemant H Alur | 1 |
#10 | James A H Harwick | 1 |
Publication | Filing date | Title |
---|---|---|
EP3525767A1 | Topical formulations and treatments | |
CA2993012A1 | Topical formulations and treatments | |
WO2011153334A2 | Bioadhesive compositions for epithelial drug delivery | |
CN101557802A | Self solidifying bioerodible barrier implant |